Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study.
about
Systemic therapy of hepatocellular carcinoma: current status and future perspectivesHedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma.Exploiting novel molecular targets in gastrointestinal cancers.Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissuesTargeting metastatic upper gastrointestinal adenocarcinomasSuppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody.Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureHCC and angiogenesis: possible targets and future directionsSystemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.Anti-angiogenic treatment of gastrointestinal malignancies.Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patientsEvolving therapies in the treatment of hepatocellular carcinomaPrognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.Gemox: a widely useful therapy against solid tumors-review and personal experience.Hepatocellular carcinoma and vitamin D: a review.New agents on the horizon in hepatocellular carcinoma.Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib.Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy.Review of angiogenesis in hepatocellular carcinoma.Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists.Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
P2860
Q26865844-D7C66080-FBA5-4B22-ACCF-E7B59C884EE6Q33695543-B9E47622-4020-44D4-AA19-8FEBD3A7428DQ34382777-F1E4D476-1C7F-402B-A02D-26179F43807EQ34605633-4DE55D1E-ED71-4EB5-A8EB-D43A66A9731DQ35000785-99908EF8-1FF2-4396-A955-3811207C5902Q35092548-2500116D-CF74-44E1-9031-E9AEAA543AA8Q35640101-3536E5CA-D6FD-45B1-A194-56B57F7FA6CEQ35698574-72FA4958-5296-4258-9C1D-3FA8385B31A0Q35913461-8DF2D4B0-D69F-4650-B16E-1DDF825BD3D5Q36353516-F4109F74-938D-4FF8-9993-75B11EDD31AAQ37015632-E40DA088-017C-4C74-B579-F7323A8F4266Q37197025-2AFE4146-9DF0-4FB6-A2D2-569AE23C4B07Q37197262-D899F66F-09EF-4AA5-A0CB-034FAAEF8B02Q37290714-511AF832-A9A8-40FF-95D6-DBEA5128072EQ37463744-4119FAF0-544C-4C78-A4C0-A2E4E8CA247EQ37564297-E15227E1-9AE4-4E3D-A2B7-086E7FC1E77AQ37584706-4FFC13F3-5B03-4B6A-B3C3-A8ED83794D8EQ37724256-A6D89ED3-9FFD-42F8-8FDA-C155B9E006F2Q37814700-65D5EB8A-967E-4EAD-8A6E-A25295BCF83FQ37924314-CF79D2AD-90CC-41D3-B955-48E7B10B9AD1Q38074429-F6BD3E74-EBDF-4334-9815-84D6C9E11DFCQ38149819-E27C8A9F-F2A8-4BFA-AEAA-0125A0C43933Q38155510-C0FD9E54-84D4-4FB9-9E89-E54B3B88112BQ38184582-1306CEC7-6CA3-4E35-9515-5ABC83AAB8FCQ38188582-D86DC9E9-C820-4928-8F07-8520526FA742Q39307416-B72C4733-6765-491D-BF1F-1CD5EB814B50Q51356864-E1B8929B-089B-4CAD-A361-77FFD11ACA00
P2860
Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prognostic significance of pre ...... arcinoma: a prospective study.
@ast
Prognostic significance of pre ...... arcinoma: a prospective study.
@en
type
label
Prognostic significance of pre ...... arcinoma: a prospective study.
@ast
Prognostic significance of pre ...... arcinoma: a prospective study.
@en
prefLabel
Prognostic significance of pre ...... arcinoma: a prospective study.
@ast
Prognostic significance of pre ...... arcinoma: a prospective study.
@en
P2093
P2860
P356
P1476
Prognostic significance of pre ...... arcinoma: a prospective study.
@en
P2093
Chien-Ming Chu
Horng-Yuan Wang
I-Shyan Sheen
Kuo-Shyang Jeng
Po-Chuan Wang
Shou-Chuan Shih
Shu-Ling Gu
Wen-Hsing Chang
Yi-Ching Wang
P2860
P304
P356
10.3748/WJG.V10.I5.643
P407
P577
2004-03-01T00:00:00Z